HG

Active Director Director DIN 10189640
DIN 10189640 First appointment Jun 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Hema Gaur

Data last updated:

Hema Gaur is a Director at Prosthetic Asia Private Limited (since 2023). The company operates in Healthcare. Prosthetic Asia Private Limited reported revenue of ₹2.09 Cr (FY 2025).

DIN 10189640
Primary Designation Director
Industry Healthcare
First Appointment 02 Jun 2023
Oldest Company Age 3 yrs
Largest company Prosthetic Asia Private Limited · ₹2.09 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Prosthetic Asia Private Limited U46909DL2023PTC415222
Director02 Jun 20232023₹2.09 Cr (FY 2025)Active

Board colleagues of Hema Gaur

NameDINCompanyDesignation
Himanshu Gaur08157514Prosthetic Asia Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Prosthetic Asia Private Limited
Premium access

Shareholding and investment profile for Hema Gaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hema Gaur

Hema Gaur currently holds 1 directorship: Prosthetic Asia Private Limited (Director, since 02 Jun 2023, revenue ₹2.09 Cr (FY 2025)).

Hema Gaur was first appointed on 02 Jun 2023 as Director at Prosthetic Asia Private Limited.

The current boards of Hema Gaur's companies include Himanshu Gaur (Prosthetic Asia Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available